# Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis

> **NCT01591200** · PHASE2 · COMPLETED · sponsor: **Stempeutics Research Pvt Ltd** · enrollment: 40 (actual)

## Conditions studied

- Alcoholic Liver Cirrhosis

## Interventions

- **BIOLOGICAL:** Allogeneic Mesenchymal Stem Cells
- **BIOLOGICAL:** Allogeneic Mesenchymal Stem Cells
- **BIOLOGICAL:** Allogeneic Mesenchymal Stem Cells

## Key facts

- **NCT ID:** NCT01591200
- **Lead sponsor:** Stempeutics Research Pvt Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01591200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01591200, "Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01591200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*